Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 6Neoplasm Metastasis 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Testicular Neoplasms 1Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hypogonadism 1Head and Neck Neoplasms 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 17Cytarabine 11venetoclax 9fludarabine 9Mycophenolic Acid 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6ruxolitinib 5Tacrolimus 5Methotrexate 5Daunorubicin 5Cyclosporine 5Azacitidine 5ponatinib 4Vincristine 4Rituximab 4Prednisone 4Peripheral Blood Stem Cell Transplantation 4Mercaptopurine 4Etoposide 4Dexamethasone 4blinatumomab 3asciminib 3Inotuzumab Ozogamicin 3Doxorubicin 3revumenib 2quizartinib 2pegfilgrastim 2pegaspargase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Mental Status and Dementia Tests × 90 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡